CAS No. |
2222132-40-1 |
中文名称 |
9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-四羟基-5,12-二氧代八氢-2H,7H-二呋喃并[3,2-d:3',2'-j][1,3,7,9]四氧杂[2,8]二磷杂十二元环-2,9-二基)双(2-氨基-3,9-二氢-6H-嘌呤-6-酮)二钠盐 |
英文名称 |
9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine-2,9-diyl)bis(2-amino-3,9-dihydro-6H-purin-6-one), disodium salt |
别名 |
Cyclic di-GMP (sodium salt);Cyclic-di-GMP disodium;guanylyl-(3'→5')-3'-guanylicacid,cyclicnucleotide,disodiumsalt;Cyclic diguanylate|||5GP-5GP disodium|||3',5'-Cyclic diguanylic acid|||Cyclic di-GMP (sodium salt)|||cyclic diguanylate disodium|||c-di-GMP|||c-di-GMP disodium;3'-Guanylic acid,guanylyl-(3'→5')-,cyclic nucleotide,sodium salt |
标准英文名 |
9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine-2,9-diyl)bis(2-amino-3,9-dihydro-6H-purin-6-one), disodium salt |
分子式 |
C20H22N10Na2O14P2 |
分子量 |
736.40
|
精确分子量 |
734.06
|
SMILES |
[O-]P1(OC[C@]([H])([C@]2(OP(OC[C@]([H])([C@]3(O1)[H])O[C@H]([C@@H]3O)N4C=NC5=C4NC(N)=NC5=O)([O-])=O)[H])O[C@H]([C@@H]2O)N6C=NC7=C6NC(N)=NC7=O)=O.[Na+].[Na+] |
标准SMILES |
[Na+].[Na+].NC1NC2=C(N=CN2[C@@H]2O[C@@H]3COP([O-])(=O)O[C@@H]4[C@@H](COP([O-])(=O)O[C@H]3[C@H]2O)O[C@H]([C@@H]4O)N2C=NC3=C2NC(N)=NC3=O)C(=O)N=1 |
用途 |
Cyclic di-GMP disodium is a STING agonist and a bacterial second messenger that coordinates various aspects of bacterial growth and behavior, including motility, virulence, biofilm formation, and cell cycle progression; it exhibits anti-proliferative activity against cancer cells, induces upregulation of CD4 receptor expression and cell cycle arrest, and is used in cancer research. |
InChIKey |
SVIXOIGPVFFABR-XDODWTFASA-L |